About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,734 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,734 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1221-1240 of 16,734 trials

UnknownResponse Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI StudyThis trial is a feasibility study prior to a planned phase III trial.NCT03266744 CompletedLapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast CancerThis phase II trial studies how well giving lapatinib ditosylate together with trastuzumab, paclitaxel, and surgery works in treating patients with breast cancer.NCT01688609·Houston, Texas and 2 others UnknownConstruction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer PatientsPatients with breast cancer malignant fungating wounds have six specific symptoms caused by wounds: malodor, pain, massive exudate, bleeding, infection, and pruritus.NCT05457309·Guangzhou, Guangdong

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingPatient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast CancerThe goal of this observational study is to evaluate how persistently patients with high-risk early breast cancer take abemaciclib 6 months after therapy start.NCT07531693·Erlangen, Bavaria

Active not recruitingInfertility Survey Among Reproductive Age Women With Gynecological and Breast CancerThis study develops infertility survey among reproductive age women with gynecological and breast cancer.NCT04678414·Houston, Texas

TerminatedAn Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)This single arm, prospective, observational study will assess the correlation between the time from start of chemotherapy to the start of Avastin (bevacizumab) treatment with…NCT01277133·Cluj-Napoca

RecruitingRobot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast ReconstructionResearch Purpose The present study is designed to generate the strongest evidence available on the role of robotic surgical systems in breast cancer surgery and to elucidate the…NCT05490433·Changwon and 16 others

CompletedNeoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast CancerThis is a single arm, proof of concept phase II clinical trial to evaluate the combination of Pembrolizumab and Carboplatin plus Paclitaxel in patients with localized TNBC (tumor…NCT06604858·A Coruña and 10 others

CompletedARRY-380 + Trastuzuamab for Breast w/ Brain MetsThe purpose of this study is to test the safety of different doses of ARRY-380 in combination with trastuzumab.NCT01921335·Boston, Massachusetts and 1 other

CompletedText Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap ClosurePrimary care visits are a key aspect of clinical care focused on helping patients to close care gaps related to preventive care such as vaccination, diabetes testing, statin…NCT05799976·St Louis, Missouri

CompletedRebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast CancerRandomized phase II trial to compare the effectiveness of two regimens of rebeccamycin analogue in treating women who have stage IIIB or stage IV breast cancer.NCT00005817·Boston, Massachusetts

UnknownTARGeted Intraoperative radioTherapy (TARGIT) Registry DatabaseThis is a prospectively registered database of patients with early breast cancer who will be treated with radiotherapy during surgery.NCT02947425·London and 2 others

UnknownDose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast CancerThe purpose of this study is to determine the efficacy and safety of dose-dense(biweekly) carboplatin and paclitaxel ± trastuzumab as neoadjuvant treatment in early breast cancer.NCT02059876·Guangzhou, Guangdong

Active not recruitingMobile Self-Management Training for Lymphedema PreventionBreast cancer is the most common cancer among women in the world and in our country and affects women negatively in many ways.NCT07043140·Malatya, Battalgazi

CompletedFluorescence Guided Surgery in Breast CancerA need for further investigation for fluorescence image-guided surgery in breast conserving surgery (BCS) has arisen following the results obtained from a phase I feasibility…NCT02583568·Groningen, Provincie Groningen

RecruitingEvaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryThe purpose of the study is to evaluate how precise the SAVI Scout MD is and how easy it is for surgeons to use during surgery.NCT07686250·Tampa, Florida

Not yet recruitingSac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBCThis study is aimed to evaluate the efficacy and safety of Sacituzumab Tirumotecan combined with Toripalimab for first-line treatment of PD-L1 positive unresectable Locally…NCT07244874

TerminatedTargeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic BCThe main hypothesis of the study is that enzalutamide induces a significant proliferative arrest in HR+/HER2-negative breast cancer falling into the PAM50 HER2-E subtype.NCT04142060·Badalona, Barcelona and 7 others

Active not recruitingTracking Triple-negative Breast Cancer Evolution Through TherapyA prospective multicentre study which aims to examine the relationship between intratumour heterogeneity (ITH) and pathological response to neoadjuvant chemotherapy in patients…NCT03077776·Clermont-Ferrand and 9 others

Enrolling by invitationValidation of TAD in HER-2 with More Than 2 Lymph NodesThe main objective of the study is to validate the DAT technique in patients with Her2-positive breast cancer who have more than two positive axillary lymph nodes at diagnosis.NCT06821490·Valencia, Valencia

PreviousPage 62 of 837Next